Description: Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
Home Page: www.sinocare.com
No. 265 Guyuan Road
Changsha,
410205
China
Phone:
86 731 8993 5581
Officers
Name | Title |
---|---|
Mr. Shao Bo Li | Chairman & GM |
Mr. An Guo Huang | CFO & Sec. of the Board |
Mr. Shi Min Wang | Deputy Gen. Mang. |
Mr. Jianwen Cai | Deputy Gen. Mang. |
Mr. Baishen Ouyang | Chairman of the Supervisory Board & Assistant to the GM |
Mr. Chungeng Chen | Supervisor & Purchasing Director |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 72.7755 |
Price-to-Book MRQ: | 6.4153 |
Price-to-Sales TTM: | 6.8527 |
IPO Date: | 2012-03-19 |
Fiscal Year End: | December |
Full Time Employees: | 3534 |